Sign in
4

Changes in Ownership

Natera, Inc. Filed Acc 0001415889-25-003418

PRESIDENT, CLINICALDIAGNOSTICS sold 1,632 shares at $177.77 ($290,121)

  • PRESIDENT, CLINICALDIAGNOSTICS acquired 3,197 shares (grant or award)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Moshkevich Solomon · PRESIDENT, CLINICALDIAGNOSTICS

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2025-02-05 Grant or award : show line 1 in the form 10b5-1 +1,675 149,878 D
2025-02-05 Grant or award : show line 2 in the form 10b5-1 +1,522 151,400 D
2025-02-06 Sale : show line 3 in the form 10b5-1 −1,632 $177.77 $290,121 149,768 D
Open-market sales · 1,632 sh · avg $177.77 · $290,121
Loading xslF345X05/form4-02072025_090205.xml…